Tenderwize
Wróć do wyszukiwania

Open House Discount Agreements for Sunitinib, ATC L01EX01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 217 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sunitinib, ATC L01EX01

30/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

30 / 100

Złożoność

40 / 100

Czynniki ryzyka

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive pharmaceutical discount agreements for Sunitinib (ATC L01EX01)
  • Open house model with uniform terms for all participants
Pokaż pełne podsumowanie

Open house non-exclusive discount agreements (Rabattverträge) for pharmaceutical products containing the active ingredient Sunitinib (ATC L01EX01) with the AOK Rheinland-Pfalz/Saarland. The open house model allows any interested pharmaceutical company to conclude a contract without a competitive selection process. The maximum contract duration is 24 months, with the earliest start on 01.06.2025 and all contracts ending by 31.05.2027. Contracts can be joined monthly. The buyer reserves the right to replace open house contracts with exclusive contracts awarded through EU-wide tenders. The notice states it is not a formal public procurement under EU directives, but published voluntarily for transparency.

Ryzyka

No minimum volume or revenue guarantee. The buyer may replace open house agreements with exclusive contracts at any tim...

The notice explicitly states it is not a public procurement under EU directives, which may limit legal remedies in case...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only authorized and marketable drugs in Germany (verified via Lauer-Taxe or AMIce database)
  • Proof of marketing authorization and pharmaceutical entrepreneur status

Administrative

  • Submission of signed contract documents by the deadline

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Agreements for Sunitinib, ATC L01EX01

Non-exclusive discount agreements for Sunitinib drugs. All interested pharmaceutical companies can participate. Contract terms are uniform, no individual negotiations. First contract start on 01.06.2025, initial submission deadline 30.04.2025. Later contracts possible monthly until 31.03.2027. The open house agreements may be terminated early if the buyer concludes exclusive contracts.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
235482-2025

Dokumenty (1)

Podobne przetargi